Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Evaluation of commercially available small RNA methods for plant samples

ABSTRACT: Evaluation of commercially available small RNA methods for plant samples

PROVIDER: PRJNA659714 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR12533300.fastq.gz	Fastqsanger.gz
	SRR12533301.fastq.gz	Fastqsanger.gz
	SRR12533302.fastq.gz	Fastqsanger.gz
	SRR12533303.fastq.gz	Fastqsanger.gz
	SRR12533304.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 96

Similar Datasets

Evaluation of commercially available small RNA methods for plant samples

Project description:Plant small RNAs are a diverse and complex set of molecules, ranging in length from 21 to 24 nt, involved in a wide range of essential biological processes. Nowadays, high-throughput sequencing is the most commonly used method for the discovery and quantification of small RNAs. However, it is known that several biases can occur during the preparation of small RNA libraries, especially using low input RNA. We used two types of plant biological samples to evaluate the performance of seven commercially available methods for small RNA library construction, using different RNA input amounts. We show that when working with plant material, library construction methods have differing capabilities to capture small RNAs, and that different library construction methods provide better results when applied to the detection of microRNAs, phased small RNAs, or tRNA-derived fragments.

2021-08-01 | GSE156973 | GEO

Fungal community from commercially available Reishi products

Project description:Fungal community from commercially available Reishi products Metagenome

| PRJNA474334 | ENA

Sequencing of commercially-available pancreatic cancer cell lines reveals selective CYP3A5 overexpression among xenobiotic-metabolizing CYPs.

Project description:Purpose: To know the expression of all cytochrome P450 (CYP) enzymes and related drug metabolizing enzymes in pancreatic cancer models Methods: We obtained expression profiles of 8 commercially-available pancreatic cancer cell lines and one non-cancerous immortalized cell line by RNA-sequencing. The pancreatic cancer cells were compared among themselves and to the non-cancerous control cells. Results: We confirmed reports that CYP3A5 is highly overexpressed in pancreatic cancer models, and additionally report that known xenobiotic-metabolizing CYPs are lowly expressed in comparison.

2020-03-01 | GSE138437 | GEO

Systematic assessment of commercially available low-input miRNA library preparation kits

Project description:Systematic assessment of commercially available low-input miRNA library preparation kits

| PRJNA552326 | ENA

Gene expression changes between primary mesothelioma tumour cells and commercially available cell lines, compared to normal primary mesothelial cells

Project description:Malignant mesothelioma (MM) is an aggressive, fatal tumour strongly associated with asbestos exposure. There is an urgent need to improve MM patient outcomes and this requires functionally validated pre-clinical models. Mesothelioma-derived cell lines provide an essential and robust tool widely used for candidate drug evaluation. Although a number of cell lines are commercially available, a detailed comparison of these lines with freshly-derived primary tumour cells to validate their suitability as pre-clinical models is lacking. Patient-derived primary mesothelioma cell lines were established and characterised by gene expression profiling. Molecular profiling revealed a significantly different transcriptome in commercially available compared with primary cell lines. Primary mesothelioma cell lines are more representative of the tumour close to its native state and show a degree of molecular diversity, thus capturing the disease heterogeneity in a patient cohort.

2018-02-01 | E-MTAB-6351 | biostudies-arrayexpress

Fluidigm96 - Evaluation of single-Cell RNA Sequencing Platforms

Project description:comparison of commercially available scRNA-Seq instrumentation using a well-defined cell line and treatment for evaluation

2021-10-06 | GSE142648 | GEO

SureCell - Evaluation of single-Cell RNA Sequencing Platforms

Project description:comparison of commercially available scRNA-Seq instrumentation using a well-defined cell line and treatment for evaluation

2021-10-06 | GSE142650 | GEO

FluidigmHT - Evaluation of single-Cell RNA Sequencing Platforms

Project description:comparison of commercially available scRNA-Seq instrumentation using a well-defined cell line and treatment for evaluation

2021-10-06 | GSE142646 | GEO

Wafergen - Evaluation of single-Cell RNA Sequencing Platforms

Project description:comparison of commercially available scRNA-Seq instrumentation using a well-defined cell line and treatment for evaluation